礼来(LLY)涨3.46% Omvoh儿童溃疡性结肠炎三期试验成功

金吾财讯
Yesterday

金吾财讯 | 礼来(LLY)盘初股价上扬,最新涨3.46%,报1283.79美元,成交额3.06亿美元。消息面上,礼来宣布,旗下Omvoh注射剂针对儿童溃疡性结肠炎患者的后期临床试验取得成功,公司计划推动这款肠道疾病疗法扩大适应症范围。礼来表示,本次试验中Omvoh的安全性表现,与该药物在成人患者身上已确认的耐受特征保持一致;试验中有4名受试者出现和试验药物无关的严重不良事件,另有2名患者因溃疡性结肠炎复发退出研究。Omvoh目前已在美国获批,用于治疗活动性溃疡性结肠炎、克罗恩病成人患者。礼来计划向全球监管机构提交本次试验数据,申请将Omvoh适应症拓展至儿童溃疡性结肠炎。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10